Group One Trading, L.P. Vbi Vaccines Inc Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.64 $8,061 - $17,790	-27,797 Reduced 27.24%	74,245 $22,000
Q4 2022 Feb 09, 2023	BUY	$0.38 - $22.5 $3,910 - $231,570	10,292 Added 11.22%	102,042 $39,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $23.4 $18,114 - $580,647	24,814 Added 37.07%	91,750 $65,000
Q2 2022 Aug 11, 2022	SELL	$0.66 - $1.81 $20,906 - $57,335	-31,677 Reduced 32.12%	66,936 $54,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $311,547 - $605,923	-245,313 Reduced 71.33%	98,613 $164,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $221,181 - $322,264	100,082 Added 41.04%	343,926 $805,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $533,061 - $708,209	190,379 Added 356.08%	243,844 $758,000
Q2 2021 Aug 10, 2021	SELL	$2.61 - $4.17 $33,316 - $53,230	-12,765 Reduced 19.27%	53,465 $179,000
Q1 2021 May 12, 2021	BUY	$2.91 - $4.32 $192,729 - $286,113	66,230 New	66,230 $206,000
Q4 2020 Feb 10, 2021	SELL	$2.15 - $3.5 $109,533 - $178,311	-50,946 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.77 - $6.17 $141,120 - $314,336	50,946 New	50,946 $146,000
Q3 2019 Nov 12, 2019	SELL	$0.47 - $1.05 $235 - $525	-500 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$0.65 - $2.12 $325 - $1,060	500 New	500 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.